Oxaliplatin-related sinusoidal obstruction syndrome mimicking metastatic liver tumors

Hepatology Research

Volumn 43, Issue 6, 2013, Pages 685-689

  Arakawa, Yusuke ^a   Shimada, Mitsuo ^a   Utsunomya, Tohru ^a   Imura, Satoru ^a   Morine, Yuji ^a   Ikemoto, Testuya ^a   Hanaoka, Jun ^a   Sugimoto, Koji ^a   Bando, Yoshimi ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Metastatic liver tumors; Oxaliplatin; Sinusoidal obstruction syndrome; Splenomegaly; Veno occlusive disease

Indexed keywords

ALPHA FETOPROTEIN; CAPECITABINE; CARBOHYDRATE ANTIGEN; CARCINOEMBRYONIC ANTIGEN; HEMOGLOBIN; INDOCYANINE GREEN; OXALIPLATIN; PERFLUBUTANE;

ADULT; ADVERSE OUTCOME; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; DRUG SAFETY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; LIVER METASTASIS; LIVER VENOOCCLUSIVE DISEASE; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RECTUM CANCER; RECTUM SURGERY; SPLENOMEGALY; THROMBOCYTE COUNT;

EID: 84878770639     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.01114.x     Document Type: Article

References (21)

1. O'Reilly DA, Poston GJ. Colorectal liver metastases: current and future perspectives. Future Oncol 2006; 2: 525-531.
2. Haruki K, Shiba H, Fujiwara Y etal. Perioperative change in peripheral blood monocyte count may predict prognosis in patients with colorectal liver metastasis after hepatic resection. J Surg Oncol 2012; 106: 31-35.
3. Beppu T, Sakamoto Y, Hasegawa K etal. A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci 2012; 19: 72-84.
4. Kim YK, Ko SW, Hwang SB etal. Detection and characterization of liver metastases: 16-slice multidetector computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging. Eur Radiol 2006; 16: 1337-1345.
5. Zorzi D, Laurent A, Pawlik TM etal. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007; 94: 274-286.
6. Levi F, Zidani R, Misset JL. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy. Lancet 1997; 350: 681-686.
7. de Gramont A, Figer A, Seymour M etal. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18: 2938-2947.
8. Douillard JY, Cunningham D, Roth AD etal. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000; 355: 1041-1047.
9. Nozawa H, Kitayama J, Sunami E etal. FOLFOX as adjuvant chemotherapy after curative resection of distant metastases in patients with colorectal cancer. Oncology 2011; 80: 84-91.
10. Soubrane O, Brouquet A, Zalinski S etal. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome. Ann Surg 2010; 251: 454-460.
11. Diaz-Rubio E, Evans TR, Tabemero J etal. Capecitabine (Xeloda) in combination with oxaliplatin: a phase I, dose-escalation study in patients with advanced or metastatic solid tumors. Ann Oncol 2002; 13: 558-565.
12. Wilmont FCRG. Senecio disease, or cirrhosis of the liver due to senecio poisoning. Lancet 1920; 2: 848-849.
13. El-Sayed MH, El-Haddad A, Fahmy OA etal. Liver disease is a major cause of mortality following allogeneic bone-marrow transplantation. Eur J Gastroenterol Hepatol 2004; 16: 1347-1354.
14. Barker CC, Anderson RA, Sauve RS etal. GI complications in pediatric patients post-BMT. Bone Marrow Transplant 2005; 36: 51-58.
15. Horn B, Reiss U, Matthay K etal. Veno-occlusive disease of the liver in children with solid tumors undergoing autologous hematopoietic progenitor cell transplantation: a high incidence in patients with neuroblastoma. Bone Marrow Transplant 2002; 29: 409-415.
16. Deleve LD, Wang X, Tsai J etal. Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition. Gastroenterology 2003; 125: 882-890.
17. Aloia T, Sebagh M, Plasse M etal. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 2006; 24: 4983-4990.
18. Bengtsson T, Orselius K, Wettero J. Role of the actin cytoskeleton during respiratory burst in chemoattractant-stimulated neutrophils. Cell Biol Int 2006; 30: 154-163.
19. Ward J, Guthrie JA, Sheridan MB etal. Sinusoidal obstructive syndrome diagnosed with superparamagnetic iron oxide-enhanced magnetic resonance imaging in patients with chemotherapy-treated colorectal liver metastases. J Clin Oncol 2008; 26: 4304-4310.
20. Shin NY, Kim MJ, Lim JS etal. Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases. Eur Radiol 2012; 22: 864-871.
21. Overman MJ, Maru DM, Charnsangavej C etal. Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury. J Clin Oncol 2010; 28: 2549-2555.